These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35283455)

  • 1. Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.
    Williams SV; Whitaker HJ; Mumford L; Callaghan C; Curtis RMK; Stowe J; Kirsebom F; Thomas J; Ushiro-Lumb I; Ravanan R; Lopez-Bernal J
    Transplantation; 2022 Jun; 106(6):e310-e311. PubMed ID: 35283455
    [No Abstract]   [Full Text] [Related]  

  • 2. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.
    Ravanan R; Mumford L; Ushiro-Lumb I; Callaghan C; Pettigrew G; Thorburn D; Gardiner D; Forsythe J;
    Transplantation; 2021 Nov; 105(11):e263-e264. PubMed ID: 34310530
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.
    Radcliffe C; Azar MM; Cohen E; Tucker M; Grubaugh ND; Malinis M
    Clin Transplant; 2022 Mar; 36(3):e14601. PubMed ID: 35064939
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
    Kamar N; Abravanel F; Marion O; Romieu-Mourez R; Couat C; Del Bello A; Izopet J
    JAMA Netw Open; 2021 Nov; 4(11):e2136030. PubMed ID: 34817587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
    Boyarsky BJ; Ou MT; Greenberg RS; Teles AT; Werbel WA; Avery RK; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 May; 105(5):e56-e57. PubMed ID: 33560728
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
    Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid-Organ Transplant Recipient Attitudes Regarding COVID-19 and the COVID-19 Vaccines.
    Jackson RC; Halim A; Lominadze Z; Timofte I; Shetty K
    Exp Clin Transplant; 2023 Jun; 21(6):543-544. PubMed ID: 36656109
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
    Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
    Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.
    Callaghan CJ; Curtis RMK; Mumford L; Whitaker H; Pettigrew G; Gardiner D; Marson L; Thorburn D; White S; Parmar J; Ushiro-Lumb I; Manas D; Ravanan R;
    Transplantation; 2023 May; 107(5):1124-1135. PubMed ID: 36727724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
    Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
    Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients.
    Mitchell J; Chiang TP; Alejo JL; Kim JD; Chang A; Abedon AT; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Massie AB; Werbel WA
    Clin Transplant; 2023 Jan; 37(1):e14868. PubMed ID: 36437691
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
    Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
    Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update.
    Mitchell J; Alejo JL; Chiang TPY; Kim J; Chang A; Abedon AT; Avery RK; Tobian AAR; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Jul; 106(7):e338-e340. PubMed ID: 35426888
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
    Mossad SB
    Am J Transplant; 2021 Dec; 21(12):4105. PubMed ID: 34212494
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.
    Villavicencio A; Ebisu Y; Raja M; Sanchez-Covarrubias AP; Reynolds JM; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13936. PubMed ID: 36067062
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Aug; 21(8):2916-2918. PubMed ID: 34101990
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
    Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
    Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Abedon AT; Teles MS; Alejo JL; Kim JD; Mitchell J; Chiang TPY; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e262-e263. PubMed ID: 35175241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.
    Chang A; Alejo JL; Abedon AT; Mitchell J; Chiang TP; Boyarsky BJ; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Feb; 106(2):e161-e162. PubMed ID: 34789691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.